A Review of New Approaches to Assessing Hepatic Function in Animals

Overview

Journal Vet Res Commun

Publisher Springer

Specialty Veterinary Medicine

Date 1987 Jan 1

PMID 3328402

Citations 1

Authors

C E Cornelius

Affiliations

Soon will be listed here.

Abstract

Although a multitude of effective liver function tests are available for use in animals, a variety of modifications of currently used tests have been recently reported. In addition, newer procedures now used in human medicine may also provide unique insights into assessing and detecting acquired hepatic disorders in animals. Examples of new procedures are: assessing microsomal mixed function oxidase activity by plasma caffeine clearance; estimating the extent of active hepatic fibrogenesis through serum procollagen-III peptide levels; determining hepatic blood flow and functional mass by the galactose elimination capacity; detecting primary hepatocellular cancer through serum or urinary ligandin levels; and to estimate the liver's maximal capacity to excrete indocyanine green independent of blood flow. In evaluating drugs as to their hepatotoxicity, function tests should be included in the liver profile which measure specific metabolic alterations unique to the compound under study.

Citing Articles

Contribution of delta bilirubin to the interpretation of hyperbilirubinemia in the horse - a pilot study.

Lumsden J, Jacobs R, Physick-Sheard P Can Vet J. 1991; 32(3):169-72.

PMID: 17423755 PMC: 1480980.

References

Kobayashi K, Sugimoto T, Makino H, Kumagai M, Unoura M, Tanaka N . Screening methods for early detection of hepatocellular carcinoma. Hepatology. 1985; 5(6):1100-5. DOI: 10.1002/hep.1840050607. View

Sherman M, Bass N, Campbell J, KIRSCH R . Radioimmunoassay of human ligandin. Hepatology. 1983; 3(2):162-9. DOI: 10.1002/hep.1840030205. View

Parraga M, Kaneko J . Total serum bile acids and the bile acid profile as tests of liver function. Vet Res Commun. 1985; 9(2):79-88. DOI: 10.1007/BF02215131. View

Wahllander A, Renner E, Preisig R . Fasting plasma caffeine concentration. A guide to the severity of chronic liver disease. Scand J Gastroenterol. 1985; 20(9):1133-41. DOI: 10.3109/00365528509088884. View

Ito S, Tsuji Y, Iwasaki A, Kitagawa N, Tamura Y, Fujii S . Relationship between guanase activity in donor blood and the incidence of posttransfusional non-A, non-B hepatitis, and a possible method for preventing posttransfusional hepatitis. Hepatology. 1986; 6(5):990-3. DOI: 10.1002/hep.1840060530. View

Ritland S, Bergan A . Plasma concentration of lipoprotein-X (LP-X) in experimental bile duct obstruction. Scand J Gastroenterol. 1975; 10(1):17-24. View

Ito S, Takaoka T, Nakaya Y, Hiasa Y, Mori H, Tanaka K . Clinical value of the determination of serum guanase activity. Studies on patients and experimental data from mongrel dogs and cultured rat hepatocytes. Gastroenterology. 1982; 83(5):1102-8. View

Bunch S, Polak D, Hornbuckle W . A modified laparoscopic approach for liver biopsy in dogs. J Am Vet Med Assoc. 1985; 187(10):1032-5. View

Fevery J, Claes J, HEIRWEGH K, De Groote J . Hyperbilirubinemia: significance of the ratio between direct-reacting and total bilirubin. Clin Chim Acta. 1967; 17(1):73-9. DOI: 10.1016/0009-8981(67)90098-8. View

10.

Bruss M, Grohn Y, Huffman E, Lindberg L . Hepatic morphology and effects of intravenous injection of sodium propionate on plasma propionate and glucose in fed and fasted dairy cattle. Am J Vet Res. 1986; 47(2):336-41. View

11.

KAPLAN M . Serum alkaline phosphatase--another piece is added to the puzzle. Hepatology. 1986; 6(3):526-8. DOI: 10.1002/hep.1840060334. View

12.

PORTMAN O, Chowdhury J, Chowdhury N, Alexander M, Cornelius C, Arias I . A nonhuman primate model of Gilbert's syndrome. Hepatology. 1984; 4(2):175-9. DOI: 10.1002/hep.1840040202. View

13.

Blanckaert N . Analysis of bilirubin and bilirubin mono- and di-conjugates. Determination of their relative amounts in biological samples. Biochem J. 1980; 185(1):115-28. PMC: 1161276. DOI: 10.1042/bj1850115. View

14.

Simionatto C, Anderson K, Drummond G, Kappas A . Studies on the mechanism of Sn-protoporphyrin suppression of hyperbilirubinemia. Inhibition of heme oxidation and bilirubin production. J Clin Invest. 1985; 75(2):513-21. PMC: 423526. DOI: 10.1172/JCI111727. View

15.

Burg A . Physiological disposition of caffeine. Drug Metab Rev. 1975; 4(2):199-228. DOI: 10.3109/03602537508993756. View

16.

Sherlock S, Dick R, van Leeuwen D . Liver biopsy today. The Royal Free Hospital experience. J Hepatol. 1985; 1(1):75-85. DOI: 10.1016/s0168-8278(85)80070-2. View

17.

Himes J, Cornelius C . Hepatic excretion and storage of sulfobromophthalein sodium in experimental hepatic necrosis in the dog. Cornell Vet. 1973; 63(3):424-31. View

18.

Lauterburg B, BIRCHER J . Expiratory measurement of maximal amino-pyrine demethylation in vivo: effect of phenobarbital, partial hepatectomy, protacaval shunt and bile duct ligation in the rat. J Pharmacol Exp Ther. 1976; 196(2):501-9. View

19.

Kurki P, Gripenberg M, Teppo A, Salaspuro M . Profiles of antinuclear antibodies in chronic active hepatitis, primary biliary cirrhosis and alcoholic liver disease. Liver. 1984; 4(2):134-8. DOI: 10.1111/j.1600-0676.1984.tb00918.x. View

20.

De Broe M, Roels F, Nouwen E, Claeys L, Wieme R . Liver plasma membrane: the source of high molecular weight alkaline phosphatase in human serum. Hepatology. 1985; 5(1):118-28. DOI: 10.1002/hep.1840050124. View